Skip to main content
CivicGate

HR 10483
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Bone Marrow Radiation Shielding Act

To direct the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs to seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment with respect to bone marrow radiation shielding for nuclear survivability.

Introduced Sep 17, 2026

Latest action (Sep 17, 2026) Referred to the House Committee on Armed Services.

Referred to
Armed Services Committee
Policy area
Armed Forces and National Security

Sponsor (1)

Money behind the sponsor

Top reported contributors to Don Bacon’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • Employer not reported $91,070
  • TENASKA $33,900
  • SANDHILLS PUBLISHING $19,800
  • COX ENTERPRISES $18,000
  • CALVERT SYSTEMS $17,180

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Don Bacon → · Outside spending →

Actions (2)
  1. Sep 17, 2026 Referred to the House Committee on Armed Services. · house
  2. Sep 17, 2026 Introduced in House

Text versions (1)
  • Introduced in House · Sep 17, 2026

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

September 17, 2026

Mr. Bacon introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To direct the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs to seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment with respect to bone marrow radiation shielding for nuclear survivability.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Bone Marrow Radiation Shielding Act”.

SEC. 2. INDEPENDENT ASSESSMENT OF BONE MARROW RADIATION SHIELDING FOR NUCLEAR SURVIVABILITY.

(a) Assessment Required.—Not later than 30 days after the date of the enactment of this Act, the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs shall seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment on whether preserving the viability of bone marrow using partial body radiation shielding can improve the survivability of an individual exposed to gamma radiation as compared to an individual without such protection.

(b) Elements.—The assessment required under subsection (a) shall examine peer-reviewed scientific literature, laboratory studies and relevant experimental data to evaluate the comparative effectiveness of preserving bone marrow using partial body radiation shielding with respect to—

(1) the likelihood of developing Acute Radiation Syndrome;

(2) the severity of Acute Radiation Syndrome when it occurs; and

(3) overall mortality rates following gamma radiation exposure.

(c) Report.—Not later than 150 days after the date of the enactment of this Act, the Assistant Secretary shall submit to the Committees on Armed Services of the House of Representatives and the Senate a report on the assessment required under subsection (a) that includes the findings of such assessment. <all>

Comments

Comments

Loading comments…